ViaDerma Inc (VDRM)

[gameccks1]

From Outside Looking In, Based On Public Information Only

I surmise the company is waiting on the long-term Company Trajectory Changing (more so than Nupelo, in my opinion) approval from insurance companies/Medicare/Medicaid for the OTC benefits for Vitastem (see excerpt from 3/2/23 news below). Because of this extending, ongoing period with no inventory on Balance Sheet (and limited availability from doctors, currently) and effectively no sales from it ($648 in 4th quarter), one would hope (ignoring track record) that management is pretty sure of successful approval SOON, and will then promptly procure inventory, with follow-on sales taking off, based on the experienced significant effectiveness by limited customers thus far. Who knows even one (or more) of the forever floated hospital deals might then ACTUALLY come to fruition?


From previous news at https://www.otcmarkets.com/stock/VDRM/news/ViaDerma-Provides-an-Update-on-Current--Future-Business-Activities?id=391919 :
ViaDerma is currently in the process of seeking approval for insurance coverage benefits for Vitastem and Vitastem Ultra. Many insurance companies including Medicare and Medicaid offer over-the-counter benefits (OTC) for non-prescription or OTC products such as the products offered by ViaDerma.